Glucosamine-6-phosphate synthetase from Escherichia coli K-12 is progressively inactivated by L-,5-(2,3-epoxycyclohexyl-4-on)alanine (anticapsin).
Glucosamine-6-phosphate synthetase from Escherichia coli K-12 is progressively inactivated by L-,5-(2,3-epoxycyclohexyl-4-on)alanine (anticapsin).
With increasing concentrations of anticapsin the reaction exhibits rate saturation: the minimum inactivation half-time is 1.15 minutes, with a K,na,,4 of 2.5 /4M.
Glutamine and competitive inhibitors protect against inactivation. Fructose-6-phosphate promotes the inactivation rate. It is concluded that anticapsin is an active-site directed glutamine analog in the reaction catalyzed by glucosamine-6-phosphate synthetase.
Glutamine is the donor of the nitrogen atom in the conversion of fructose-6-phosphate to glucosamine-6-phosphate catalyzed by enzymes from both microbial) and mammalian cells2)
This reaction is catalyzed by the enzyme glucosamine-6-phosphate synthetase (2-amino-2-deoxy-D-glucose-6-phosphate ketol-isomerase, EC 5.3. Recently it has been postulated that anticapsin acts as a glutamine analog and irreversibly inhibits the glucosamine-6-phosphate synthetase activity by covalently binding to the active site of the enzyme4, ' .
The present paper describes the results of studies on the interaction of anticapsin with partially purified glucosamine-6-phosphate synthetase from Escherichia coli K-12 and shows that the enzyme is irreversibly inactivated by the inhibitor.
Materials and Methods
Cells of E. coli K-12 strain 3000 Hfr were grown with vigorous aeration in CGPY" medium for about 18 hours at 35°C. After two washings with buffer A at 4°C, cells were resuspended in small volume of buffer B and stored at -22°C until used. Glucosamine-6-phosphate synthetase was prepared using the procedure described by GHOSH et al.1) up to the elution from DEAF-cellulose, followed by chromatography on DEAE-cellulose column as described by NORRMANN et a1.9). The fractions with high glucosamine-6-phosphate synthetase activity were purified at least on the Sephacryl S-300 column. All purification steps were conducted in buffer B. The partially purified glucosamine synthetase had a specific activity of 7.2 pmol GIcN-6-P per mg of protein under standard assay conditions. The enzyme stored in buffer B at 4°C was relatively stable for several weeks.
The enzyme activity was assayed at 37°C for 30 minutes in 1-ml reaction mixture containing 15 mm fructose-6-phosphate dipotassium salt, 10 mm L-glutamine, 1 mm dithiothreitol, 1 mm ethyleneglycolbis (13-aminoethylether)-N,N'-tetraacetic acid (EGTA), 25 mm potassium phosphate buffer pH 7.5 and enzyme protein. The formation of glucosamine-6-phosphate was determined by the previously described method7). Protein was determined by the LOWRY method as described by LAYNE10). For a change of buffer a sample of enzyme in buffer B is filtered through a Bio-Gel P-2 column previously equilibrated with buffer C.
For inactivation experiments by anticapsin or glutamine analogs 0.25 ~ 0.30 mg of enzyme protein in buffer C was incubated at 30°C with various concentrations of inhibitors and in the presence of fructose-6-phosphate at 15 mm. To follow the inactivation process the enzyme inhibitor complex was separated by the centrifuge-column procedures11). Aliquots 200,ul were withdrawn at several time intervals during the course of the reaction and transferred to the top of a small (1 ml Sephadex G-25 in buffer B) column and centrifuged 1 minute at 200 x g. Appropriate aliquots of effluent were used for determination of residual enzyme activity by standard assay procedures.
Buffers: Buffer A; 25 mm potassium phosphate buffer pH 7.5, 1 mm EGTA, 5 mm dithiothreitol: Buffer B; 25 mm potassium phosphate buffer pH 7.5, 1 mm EGTA, 2 mm dithiothreitol, 10 mM L-glutamine and 500 mm sucrose: Buffer C; 25 mm potassium phosphate buffer pH 7.5, 1 mm EGTA, 1 mM dithiothreitol and 500 mm sucrose.
Chemicals
Anticapsin was a gift from Dr. N. NEUSS, Eli Lilly, Indianapolis. 6-Diazo-5-oxo-L-norleucine, azaserine, albizziin, glutamic acid--, -monohydroxamate, glutamic acid-r-methyl ester and glutamic acidr-hydrazide were from Sigma (St. Louis, Mo.). All other chemicals were purchased from Serva (Heidelberg).
Results

Inactivation by Anticapsin and Some Glutamine Analogs
Incubation in 25 mm potassium phosphate buffer pH 7.5 containing: 1 mM EGTA, 1 mm dithiothreitol and one of the substrates: the fructose-6-phosphate at 15 mm and partially purified glucosamine-6-phosphate synthetase with anticapsin resulted in a time dependent loss of enzyme activity. The ratio of the remaining activity in the presence of anticapsin (E) to that of the control (E°) measured at the same times of incubation was plotted vs. time in a semilogarithmic graph as shown in Fig. 2 . The inactivation followed pseudo-first-order reaction kinetics, the rate of which was directly related to the inhibitor concentration.
Using the slopes of the straight lines, the values of kapp were calculated.
The dependence of the observed rate constant for inactivation on the anticapsin concentration ( Fig. 3) indicated that the inhibitor reversibly binds to the enzyme prior to irreversible inactivation:
where: E is the enzyme, I is the inhibitor, E•I is the reversible enzyme inhibitor complex, E-I is the enzyme irreversibly modified, Kiinact is the dissociation constant of E-I and kmas is the maximum inactivation rate constant at infinite inhibitor concentration.
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The presence of the substrate fructose-6-phosphate accelerates the inactivation. In its absence, the value of Kinact increased to 13.3 ,uM; in contrast the maximum inactivation rate constant showed no significant change (9 x 10-3/second). The acceleration of inactivation by fructose-6-phosphate is ascribed to ordered binding of first fructose-6-phosphate and then anticapsin.
The glutamine analog 6-diazo-5-oxo-L-norleucine also strongly inactivates the glucosamine-6-phosphate synthetase from E. coli K-12 (data not shown). The determined Kimact value of 96 /(M is only one order of magnitude higher than the value for inactivation caused by anticapsin. Other glutamine analogs such as azaserine and albizziin at concentrations of 5 mm do not cause significant inactivation of the enzyme.
At a concentration of 1 mm complete inactivation of the enzyme could be achieved within 30 minutes by thiol-group reagents: iodoacetamide and N-ethylmaleimide. At a concentration of 100 pM these reagents caused inactivation expressed by inactivation rate constants of 0.4 x 10-3/second and 3.3 x 10-3/second respectively.
Inhibitory Properties of Anticapsin on Glucosamine-6-phosphate
Synthetase Activity
The glucosamine-6-phosphate synthetase activity was assayed in the presence of various concen- pl aliquots were removed, and the activity remaining was determined as before.
6-phosphate synthetase in the process of inactivation, one should expect that the presence of the substrate glutamine, as well as competitive inhibitors of the enzyme activity, must impair the inactivation reaction. Glucosamine-6-phosphate synthetase was prepared from E. coli K-12 strain 3000 Hfr to about 60% of purity as checked by polyacrylamide gel electrophoresis.
The molecular weight of glucosamine-6-phosphate synthetase was estimated by gel filtration, on Sephacryl S-300 and to be 90,0001 5,000.
Incubation of partially purified glucosamine-6-phosphate synthetase from E. coli K-12 with the competitive inhibitor anticapsin (Fig. 4) causes time-dependent, pseudo-first order loss of enzyme activity. Gel filtration of the inactivated enzyme does not cause its reactivation, consistent with mechanism of inactivation involving covalent modification of the enzyme1e~. Saturation kinetics are observed with a K , et of 2.5 µM and k,,,a , of 1 x 10-2/second, excluding the possibility that inactivation occurs by a nonspecific bimolecular mechanism. The binding of anticapsin to the glutamine binding site of the enzyme occurs by the sequential ordered mechanism. The observation that the rate of inactivation is diminished in the presence of glutamine and of competitive inhibitors, indicated that covalent modification occurs at the enzyme active site.
All thus far examined glutamine analogs: 6-diazo-5-oxo-L-norleucine, azaserine, albizziin, 2-amino-4-oxo-5-chloropentanoic acid17) and a-amino-3-chloro-4,5-dihydro-5-isoxazolacetic acid18) covalently bind to the active site cysteine residue that is essential for glutamine utilization.
The identification of the covalently modified amino acid residue (probably cysteine) in the active site of the enzyme upon the action of anticapsin requires further studies. The exceptional effectiveness of anticapsin as an enzyme inactivator can not be explained just by the high affinity to the enzyme binding site and chemical reactivity of the moiety participating in the formation of a covalent bond. We postulate that due to the specific structure of anticapsin, proximity and orientation effects occur upon the binding of the inhibitor by the enzyme glutamine binding site.
Based on the obtained results it can be concluded that anticapsin is an active-site directed glutamine analog in the reaction catalyzed by glucosamine-6-phosphate synthetase.
